{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:14:47Z","timestamp":1793394887290,"version":"4.5.0"},"reference-count":71,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Metabolic-associated fatty liver disease (MAFLD) is a chronic liver condition with limited therapeutic options. To identify novel drug targets, we integrated bioinformatics, Mendelian randomization (MR), and colocalization analyses. Using the Gene Expression Omnibus (GEO) database, we identified differentially expressed genes and constructed protein\u2013protein interaction (PPI) networks, pinpointing 10 hub genes. MR and colocalization analyses revealed that Ubiquitin-like with PHD and ring finger domains 1 (UHRF1) is causally associated with MAFLD and driven by the same causal variant locus, suggesting its potential as a therapeutic target. Molecular docking identified disogenin as a candidate small-molecule drug targeting UHRF1. Drug affinity responsive target stability (DARTS) assays confirmed direct binding between UHRF1 and disogenin. In vitro, disogenin significantly reduced UHRF1 mRNA and protein levels induced by free fatty acids (FFA) in AML12 and HepG2 cells, accompanied by decreased cellular total cholesterol (TC) and triglyceride (TG) levels. In vivo, disogenin administration alleviated hepatic lipid accumulation, inflammation, and fibrosis in methionine\/choline-deficient (MCD)-diet-fed mice. This study identifies UHRF1 as a promising therapeutic target for MAFLD and validates disogenin as a potential therapeutic agent, providing a foundation for further investigation.<\/jats:p>","DOI":"10.3390\/ijms26073166","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:25:02Z","timestamp":1743391502000},"page":"3166","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Novel Therapeutic Targets for MAFLD Based on Bioinformatics Analysis Combined with Mendelian Randomization"],"prefix":"10.3390","volume":"26","author":[{"given":"Jialin","family":"Ren","sequence":"first","affiliation":[{"name":"Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225100, China"},{"name":"Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225100, China"},{"name":"Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou 225100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3350\/cmh.2023.0277","article-title":"Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity","volume":"29","author":"Kim","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3350\/cmh.2023.0291","article-title":"Waiting for the changes after the adoption of steatotic liver disease","volume":"29","author":"Yoon","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zeng, T., Chen, G., Qiao, X., Chen, H., Sun, L., Ma, Q., Li, N., Wang, J., Dai, C., and Xu, F. (2022). NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.823140"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/17474124.2020.1780915","article-title":"Genetics and epigenetics purpose in nonalcoholic fatty liver disease","volume":"14","author":"Uribe","year":"2020","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/JHC.S344559","article-title":"Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges","volume":"9","author":"Ahmad","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Huang, J., Li, J., Peng, Y., Cui, T., Guo, J., Duan, S., Zhou, K., Huang, S., Chen, J., and Yi, Q. (2024). The lack of PPAR\u03b1 exacerbated the progression of non-alcoholic steatohepatitis in mice with spleen deficiency syndrome by triggering an inflammatory response. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1381340"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/17446651.2020.1740588","article-title":"Nonalcoholic fatty liver disease, insulin resistance, and sweeteners: A literature review","volume":"15","author":"Kakleas","year":"2020","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.28392","article-title":"Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice","volume":"63","author":"Marchesini","year":"2016","journal-title":"Hepatology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1080\/21655979.2021.1938498","article-title":"Potential role of a three-gene signature in predicting diagnosis in patients with myocardial infarction","volume":"12","author":"Yao","year":"2021","journal-title":"Bioengineered"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e37645","DOI":"10.1097\/MD.0000000000037645","article-title":"Exploring the evolutionary mechanism of hepatitis B and gastric cancer based on Mendelian randomization combined with bioinformatics analysis","volume":"103","author":"Cai","year":"2024","journal-title":"Medicine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: Genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian Randomization as an Approach to Assess Causality Using Observational Data","volume":"27","author":"Sekula","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Xu, F.-B., Hu, S., Wang, J.-J., and Wang, X.-Z. (2024). Utilizing systematic Mendelian randomization to identify potential therapeutic targets for mania. Front. Psychiatry, 15.","DOI":"10.3389\/fpsyt.2024.1375209"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41573-022-00561-w","article-title":"Using human genetics to improve safety assessment of therapeutics","volume":"22","author":"Carss","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Aguet","year":"2020","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1222794","article-title":"Systematic Localization of Common Disease-Associated Variation in Regulatory DNA","volume":"337","author":"Maurano","year":"2012","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt.1662","article-title":"Discovery and characterization of chromatin states for systematic annotation of the human genome","volume":"28","author":"Ernst","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrg3461","article-title":"Pleiotropy in complex traits: Challenges and strategies","volume":"14","author":"Solovieff","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41419-023-05895-w","article-title":"UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"175522","DOI":"10.1016\/j.ejphar.2023.175522","article-title":"Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation","volume":"942","author":"Peng","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.stem.2016.03.013","article-title":"Activation of Endogenous Retroviruses in Dnmt1\u2212\/\u2212 ESCs Involves Disruption of SETDB1-Mediated Repression by NP95 Binding to Hemimethylated DNA","volume":"19","author":"Sharif","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41422-021-00565-y","article-title":"Nuclear UHRF1 is a gate-keeper of cellular AMPK activity and function","volume":"32","author":"Xu","year":"2022","journal-title":"Cell Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-21-1258","article-title":"NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy","volume":"29","author":"Pinter","year":"2023","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Vakayil, M., Madani, A.Y., Agha, M.V., Majeed, Y., Hayat, S., Yonuskunju, S., Mohamoud, Y.A., Malek, J., Suhre, K., and Mazloum, N.A. (2024). The E3 ubiquitin-protein ligase UHRF1 promotes adipogenesis and limits fibrosis by suppressing GPNMB-mediated TGF-\u03b2 signaling. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-62508-y"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Tohda, C., Yang, X., Matsui, M., Inada, Y., Kadomoto, E., Nakada, S., Watari, H., and Shibahara, N. (2017). Diosgenin-Rich Yam Extract Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind, Crossover Study of Healthy Adults. Nutrients, 9.","DOI":"10.3390\/nu9101160"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Xin, J., Cheng, W., Yu, Y., Chen, J., Zhang, X., and Shao, S. (2021). Diosgenin From Dioscorea Nipponica Rhizoma Against Graves\u2019 Disease\u2014On Network Pharmacology and Experimental Evaluation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.806829"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Li, R., Zheng, Y., Song, M., Zhang, S., Sun, Y., Wei, M., and Fan, X. (2022). Diosgenin Ameliorates Non-alcoholic Fatty Liver Disease by Modulating the Gut Microbiota and Related Lipid\/Amino Acid Metabolism in High Fat Diet-Fed Rats. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.854790"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.sjbs.2020.11.045","article-title":"Regulatory effect of diosgenin on lipogenic genes expression in high-fat diet-induced obesity in mice","volume":"28","author":"Khateeb","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.510280118","article-title":"Effects of disogenin, A plant-derived steroid, on bile secretion and hepatocellular cholestasis induced by estrogens in the rat","volume":"28","author":"Accatino","year":"1998","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.20540","article-title":"Diosgenin-induced biliary cholesterol secretion in mice requires Abcg8","volume":"41","author":"Kosters","year":"2005","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1080\/01480545.2020.1814803","article-title":"Diosgenin inhibits TGF-\u03b21\/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis","volume":"45","author":"Babu","year":"2022","journal-title":"Drug Chem. Toxicol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"109885","DOI":"10.1016\/j.cbi.2022.109885","article-title":"Diosgenin inhibits ER stress-induced inflammation in aorta via iRhom2\/TACE mediated signaling in experimental diabetic rats: An in vivo and in silico approach","volume":"358","author":"Prasad","year":"2022","journal-title":"Chem. Interact."},{"key":"ref_35","first-page":"1089","article-title":"Diosgenin prevents high-fat diet-induced rat non-alcoholic fatty liver disease through the AMPK and LXR signaling pathways","volume":"41","author":"Cheng","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Kim, A., and Benavente, C.A. (2024). Oncogenic Roles of UHRF1 in Cancer. Epigenomes, 8.","DOI":"10.3390\/epigenomes8030026"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jtho.2020.10.015","article-title":"Epigenetic Modifier UHRF1 May Be a Potential Target in Malignant Pleural Mesothelioma","volume":"16","author":"Baird","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"16223","DOI":"10.1074\/jbc.M113.527424","article-title":"Poly (ADP-ribose) polymerase 1 (PARP1) associates with E3 ubiquitin-protein ligase UHRF1 and modulates UHRF1 biological functions","volume":"289","author":"Wolf","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Theys, C., Lauwers, D., Perez-Novo, C., and Berghe, W.V. (2022). PPAR\u03b1 in the Epigenetic Driver Seat of NAFLD: New Therapeutic Opportunities for Epigenetic Drugs?. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123041"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s41232-022-00235-5","article-title":"Role of the Hippo pathway in liver regeneration and repair: Recent advances","volume":"42","author":"Pibiri","year":"2022","journal-title":"Inflamm. Regen."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.3350\/cmh.2022.0437","article-title":"Pharmacological advances in the treatment of nonalcoholic fatty liver diseases: Focused on global results of randomized controlled trials","volume":"29","author":"An","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wagner, N., and Wagner, K.-D. (2020). The Role of PPARs in Disease. Cells, 9.","DOI":"10.3390\/cells9112367"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"R\u00e9gnier, M., Polizzi, A., Smati, S., Lukowicz, C., Fougerat, A., Lippi, Y., Fouch\u00e9, E., Lasserre, F., Naylies, C., and B\u00e9touli\u00e8res, C. (2020). Hepatocyte-specific deletion of Ppar\u03b1 promotes NAFLD in the context of obesity. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-63579-3"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wagner, N., and Wagner, K.D. (2020). PPAR Beta\/Delta and the Hallmarks of Cancer. Cells, 9.","DOI":"10.3390\/cells9051133"},{"key":"ref_45","first-page":"451","article-title":"Peroxisome proliferator-activated receptor \u03b4 and gastric cancer (Review)","volume":"22","author":"Wu","year":"2009","journal-title":"Oncol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fhu, C.W., and Ali, A. (2020). Fatty Acid Synthase: An Emerging Target in Cancer. Molecules, 25.","DOI":"10.3390\/molecules25173935"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2010.05.019","article-title":"Peroxisome proliferator activated receptor \u03b1 (PPAR\u03b1) and PPAR gamma coactivator (PGC-1\u03b1) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements","volume":"325","author":"Song","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s11033-021-07097-z","article-title":"Effect of Quercetin on the fructose-activated human hepatic stellate cells, LX-2, an in-vitro study","volume":"49","author":"Shakerian","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Armisen, J., Rauschecker, M., Sarv, J., Liljeblad, M., Wernevik, L., Niazi, M., Kn\u00f6chel, J., Eklund, O., Sandell, T., and Sherwood, J. (J. Hepatol., 2025). AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials, J. Hepatol., in press.","DOI":"10.1016\/j.jhep.2024.12.046"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Jiao, S., Ren, Q., Chen, L., Zhou, Z., Cai, Z., Huang, W., Wang, B., Chen, S., Wang, W., and Cao, Z. (J. Med. Chem., 2025). Discovery of First-in-Class FXR and HSD17B13 Dual Modulator for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease, J. Med. Chem., ASAP Article.","DOI":"10.1021\/acs.jmedchem.4c02720"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Ciociola, E., Dutta, T., Sasidharan, K., Kovooru, L., Noto, F.R., Pennisi, G., Petta, S., Mirarchi, A., Maurotti, S., and Scopacasa, B. (2024). MARC1 downregulation reduces hepatocyte lipid content by increasing beta-oxidation. Clin. Mol. Hepatol., accepted.","DOI":"10.3350\/cmh.2024.0642"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jconrel.2025.02.008","article-title":"Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum","volume":"380","author":"Hong","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3350\/cmh.2023.0356","article-title":"Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease","volume":"30","author":"Chang","year":"2024","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jtho.2020.08.024","article-title":"UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma","volume":"16","author":"Reardon","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"ref_57","first-page":"n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): Explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"ref_58","first-page":"121","article-title":"Centrality Analysis of Protein-Protein Interaction Networks and Molecular Docking Prioritize Potential Drug-Targets in Type 1 Diabetes","volume":"19","author":"Soofi","year":"2020","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Chin, C.-H., Chen, S.-H., Wu, H.-H., Ho, C.-W., Ko, M.-T., and Lin, C.-Y. (2014). cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol., 8.","DOI":"10.1186\/1752-0509-8-S4-S11"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"Claringbould","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","article-title":"PhenoScanner: A database of human genotype\u2013phenotype associations","volume":"32","author":"Staley","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"McGlone, E.R., Hope, D.C., Davies, I., Dore, M., Goldin, R., Jones, B., Liu, Z., Li, J.V., Vorkas, P.A., and Khoo, B. (2024). Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity. Biomed. Pharmacother., 176.","DOI":"10.1016\/j.biopha.2024.116888"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/gtmb.2024.0085","article-title":"High Frequency of Ancestral Haplotype A of Fatty Acid Desaturase Genes in the Yakut Population","volume":"28","author":"Pavlova","year":"2024","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2147\/DMSO.S462459","article-title":"Association Between the Hepatic Steatosis Index and Risk of Incident Type 2 Diabetes Mellitus in the Normoglycemic Population:A Longitudinal Prospective Study in Japan","volume":"17","author":"Si","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"100437","DOI":"10.1016\/j.xcrm.2021.100437","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Battle","year":"2017","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Giambartolomei, C., Vukcevic, D., Schadt, E.E., Franke, L., Hingorani, A.D., Wallace, C., and Plagnol, V. (2014). Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet., 10.","DOI":"10.1371\/journal.pgen.1004383"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","article-title":"A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits","volume":"12","author":"Foley","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches","volume":"109","author":"Zuber","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"115138","DOI":"10.1016\/j.jep.2022.115138","article-title":"The mechanism of dioscin preventing lung cancer based on network pharmacology and experimental validation","volume":"292","author":"Xi","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Ren, Y.-S., Li, H.-L., Piao, X.-H., Yang, Z.-Y., Wang, S.-M., and Ge, Y.-W. (2021). Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application. Biochem. Pharmacol., 194.","DOI":"10.1016\/j.bcp.2021.114798"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/7\/3166\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:05:13Z","timestamp":1760029513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/7\/3166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":71,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["ijms26073166"],"URL":"https:\/\/doi.org\/10.3390\/ijms26073166","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]}}}